Jazz Pharmaceuticals (JAZZ) News Today $121.63 -0.34 (-0.28%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$121.82 +0.19 (+0.16%) As of 02/4/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period 2,110 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Institute for Wealth Management LLC.Institute for Wealth Management LLC. bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,110 shares of the specialty pharmaceuticalFebruary 2 at 4:53 AM | marketbeat.comShort Interest in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Drops By 8.3%Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 3,850,000 shares, a decrease of 8.3% from the December 31st total of 4,200,000 shares. Based on an average daily trading volume, of 606,000 shares, the days-to-cover ratio is currently 6.4 days. Approximately 6.7% of the company's stock are short sold.February 2 at 12:58 AM | marketbeat.comWhat is Leerink Partnrs' Forecast for JAZZ FY2024 Earnings?February 1, 2025 | americanbankingnews.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by BTC Capital Management Inc.BTC Capital Management Inc. lifted its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 9.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,653 shares of the specialty pharmaceutiJanuary 31, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Robeco Institutional Asset Management B.V.Robeco Institutional Asset Management B.V. increased its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 20.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 201,304 shares oJanuary 31, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Forecast for JAZZ EarningsJazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) - Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for Jazz Pharmaceuticals in a note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the specialty pharmaceutical companyJanuary 30, 2025 | marketbeat.comKBC Group NV Boosts Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)KBC Group NV raised its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 3.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 236,318 shares of the specialty pharmaceuticalJanuary 29, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Rating of "Moderate Buy" by AnalystsJanuary 28, 2025 | americanbankingnews.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of "Moderate Buy" by AnalystsShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) have received an average rating of "Moderate Buy" from the fifteen research firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and thirteen haveJanuary 28, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Pacer Advisors Inc.Pacer Advisors Inc. raised its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 5.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,214,480 shares of the specialty pharmaceutical company's stock afterJanuary 27, 2025 | marketbeat.comHuge Insider Buy in Entertainment Giant, and MoreJanuary 26, 2025 | msn.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Perpetual LtdPerpetual Ltd lessened its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 12.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 594,388 shares of the specialty pharmaceutical company's stock after selling 81,January 21, 2025 | marketbeat.com45,463 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by Lmcg Investments LLCLmcg Investments LLC purchased a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 45,463 shares of the specialty pharmaceutical company's stock, valued at appJanuary 21, 2025 | marketbeat.comMassMutual Private Wealth & Trust FSB Acquires 17,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MassMutual Private Wealth & Trust FSB raised its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 26,389.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,748 shares of the specialty pharJanuary 21, 2025 | marketbeat.com2,442 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Aaron Wealth Advisors LLCAaron Wealth Advisors LLC bought a new stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,442 shares of the specialty pharmaceutical company's stock, valued at approxiJanuary 21, 2025 | marketbeat.com5,811 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by Arkadios Wealth AdvisorsArkadios Wealth Advisors purchased a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 5,811 shares of the specialty pharmaceutical company's stock, valued atJanuary 21, 2025 | marketbeat.comKera Capital Partners Inc. Invests $288,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Kera Capital Partners Inc. bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 2,336 shares of the specialty pharmaceutical company's stock, valued at approximately $288,000. A numberJanuary 19, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Sees Significant Decline in Short InterestJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) was the recipient of a significant drop in short interest in December. As of December 31st, there was short interest totalling 3,850,000 shares, a drop of 8.3% from the December 15th total of 4,200,000 shares. Based on an average daily volume of 606,000 shares, the days-to-cover ratio is presently 6.4 days. Currently, 6.7% of the shares of the stock are sold short.January 18, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wedge Capital Management L L P NCWedge Capital Management L L P NC decreased its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 16.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 243,005 shares of the specialty pharmaceuJanuary 18, 2025 | marketbeat.comTeva Pharmaceutical (TEVA) Receives a Buy from Piper SandlerJanuary 17, 2025 | markets.businessinsider.comBiogen (BIIB) Receives a Hold from Piper SandlerJanuary 17, 2025 | markets.businessinsider.comEmpirical Asset Management LLC Buys Shares of 43,520 Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Empirical Asset Management LLC purchased a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 43,520 sharesJanuary 17, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Hennion & Walsh Asset Management Inc.Hennion & Walsh Asset Management Inc. lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 13.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,894 shares of the specialty pharJanuary 16, 2025 | marketbeat.comBurney Co. Acquires 4,079 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Burney Co. boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 20.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,840 shares of the specialty pharmaceutical coJanuary 16, 2025 | marketbeat.comJazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks NowJanuary 15, 2025 | insidermonkey.comJazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks NowJanuary 15, 2025 | msn.comJP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipelineJanuary 15, 2025 | finance.yahoo.comRBC Capital Sticks to Its Hold Rating for Pacira Pharmaceuticals (PCRX)January 15, 2025 | markets.businessinsider.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Bruce C. Cozadd Sells 1,500 SharesJanuary 7, 2025 | insidertrades.comInsider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Sells 1,500 Shares of StockJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) CEO Bruce C. Cozadd sold 1,500 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $123.43, for a total value of $185,145.00. Following the sale, the chief executive officer now owns 425,525 shares of the company's stock, valued at $52,522,550.75. This represents a 0.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.January 6, 2025 | marketbeat.comCentre Asset Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Centre Asset Management LLC bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 75,803 shares of the specialty pharmaceutical compJanuary 3, 2025 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Rating of "Moderate Buy" by BrokeragesJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fifteen ratings firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and thirteen have issued aJanuary 3, 2025 | marketbeat.comJPMorgan Chase & Co. Has $168.85 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)JPMorgan Chase & Co. decreased its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 1.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,515,534 shares of the specialty pharmaceutical company's stoJanuary 1, 2025 | marketbeat.comTD Cowen Keeps Their Buy Rating on Axsome Therapeutics (AXSM)December 30, 2024 | markets.businessinsider.comPrincipal Financial Group Inc. Sells 66,821 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Principal Financial Group Inc. lessened its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 31.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 142,938 shares of the specialty pharmaceutical compaDecember 28, 2024 | marketbeat.comJazz Pharmaceuticals: Should Sing A Better Tune In 2025December 23, 2024 | seekingalpha.comBarclays PLC Has $4.37 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Barclays PLC increased its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 19.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,210 shares of the specialtyDecember 22, 2024 | marketbeat.comSanctuary Advisors LLC Buys 9,804 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Sanctuary Advisors LLC boosted its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 502.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,754 shares of the specialty pharmaceutical compaDecember 21, 2024 | marketbeat.comJazz Pharmaceuticals Shows Improved Relative Strength; Still Shy Of BenchmarkDecember 21, 2024 | msn.com22,356 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Purchased by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 22,356 shares of the specialty pharmaceutical company's stock, valued at approximaDecember 18, 2024 | marketbeat.comJazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces CEO Succession PlanDecember 17, 2024 | finanznachrichten.deJazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | finanznachrichten.deJazz Pharmaceuticals (JAZZ) Gets a Buy from TD CowenDecember 17, 2024 | markets.businessinsider.comJazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | prnewswire.comJazz Pharma's Bruce Cozadd to Retire as CEODecember 17, 2024 | marketwatch.comJazz Pharmaceuticals Announces CEO Bruce Cozadd’s Retirement PlanDecember 17, 2024 | markets.businessinsider.comJazz Pharmaceuticals CEO Bruce Cozadd to retire by end of 2025December 17, 2024 | markets.businessinsider.comJazz Pharmaceuticals Announces CEO Succession PlanDecember 16, 2024 | prnewswire.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Franklin Resources Inc.Franklin Resources Inc. lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 4.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,118,688 shares of the specialty pharmaceutical company's stock after aDecember 16, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Has $2.24 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Teachers Retirement System of The State of Kentucky lowered its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 81.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,138 sDecember 16, 2024 | marketbeat.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼1.240.42▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼1010▲JAZZ Articles Average Week Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News CORT News PRGO News SUPN News PCRX News OMER News NKTR News ASMB News CPIX News LLY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
